Möchten Sie immer auf dem neuesten Stand bleiben?

CRL Cites Deficiencies at Third-Party Manufacturing Facility No Efficacy or Clinical Safety Deficiencies Identified SEATTLE and VANCOUVER, British Columbia, June 22, 2026 (GLOBE NEWSWIRE) --...

The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density (BMD) at Month 12, would support Entera’s plan to...

AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) robs people of control over their own bodies — slowly, relentlessly and without a cure. More...

Toronto, ON, June 22, 2026 (GLOBE NEWSWIRE) -- Fengate Asset Management (“Fengate”) today released its 2025 Sustainability Report, detailing how the firm continues to integrate responsible...

Vancouver, Canada, June 22, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development...

-- RMAT designation granted based on Phase 1/2 clinical data, including results previously published in The New England Journal of Medicine, demonstrating PM359’s potential to address unmet need in...

SPRINGDALE, Ark., June 22, 2026 (GLOBE NEWSWIRE) -- Tyson Foods is expanding the high-performing Tyson Chicken Cups with three bold new flavors: Garlic & Herb, BBQ and Harissa, further...

TETmedical, Inc. a clinical stage medical diagnostic company received FDA breakthrough technology designation for its NSE-Functional Activity Stroke Test

PHILADELPHIA, June 22, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development...

FDA’s rolling review process is intended to facilitate expedited review, enabling FDA to begin evaluating completed sections of the NDA before the full application is submitted Palvella remains on...